Pergami Paola, Abraham Lisa
Department of Pediatrics, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506-9214, USA.
J Child Neurol. 2011 Jul;26(7):844-50. doi: 10.1177/0883073810395142. Epub 2011 May 6.
To investigate the impact of anticoagulation on short-term outcome (1 month) in neonates with cerebral sinovenous thrombosis, the authors conducted a retrospective chart review of neonates admitted to 2 tertiary hospitals over a 5- and 8-year period, respectively. Neonates with confirmed radiographic evidence of cerebral sinovenous thrombosis were included. Eighteen total patients treated with hydration only were identified. Approximately 50% of these neonates showed clot extension or other complications on follow-up imaging that were obtained within 72 hours with either magnetic resonance imaging or computed topography. Five neonates were treated with anticoagulation, and none of these patients developed new infarcts or hemorrhages. The results of this retrospective study suggest that anticoagulation is safe in neonates with cerebral sinovenous thrombosis. Early follow-up scans can help treatment decision. Larger studies are needed to develop standardized guidelines for the evaluation and treatment of neonatal cerebral sinovenous thrombosis.
为研究抗凝治疗对新生儿脑静脉窦血栓形成短期(1个月)预后的影响,作者分别对两家三级医院在5年和8年期间收治的新生儿进行了回顾性病历审查。纳入有确诊的脑静脉窦血栓形成影像学证据的新生儿。共确定18例仅接受补液治疗的患者。这些新生儿中约50%在随访成像(72小时内通过磁共振成像或计算机断层扫描获得)中出现血栓扩展或其他并发症。5例新生儿接受了抗凝治疗,这些患者均未出现新的梗死或出血。这项回顾性研究的结果表明,抗凝治疗对患有脑静脉窦血栓形成的新生儿是安全的。早期随访扫描有助于治疗决策。需要开展更大规模的研究以制定新生儿脑静脉窦血栓形成评估和治疗的标准化指南。